Brief: Chr. Hansen Q2 Earnings Top Consensus
13/04/2023 07:08
Apr 13 (Reuters) - Chr. Hansen Q2 organic growth 11% vs. estimate 6.5%. * Q2 revenue EUR 338 million vs. estimate EUR 329 million * Q2 adjusted EBIT EUR 91 million vs. estimate EUR 86 million * Q2 adjusted EBIT margin 27% vs. estimate 26.2% * Q2 net income EUR 58.7 million
Recent news on Chr Hansen Holding A/S
See all newsJefferies sees above peer growth for Novozymes, ups to 'buy'
Brief: Combination Of Novozymes, Chr. Hansen Is Completed
Brief: Novozymes Says All Necessary Regulatory Approvals Obtained For Combination Novozymes And Chr. Hansen
European Commission clears Novozymes, Chr. Hansen merger (updated)
European Commission clears Novozymes, Chr. Hansen merger